Skip to content
HowShorted

Hims & Hers Health, Inc. short interest in 2025

In 2025, Hims & Hers Health, Inc.'s disclosed short interest ran from 25.90% of shares outstanding on 15 Jan 2025 to 29.47% on 31 Dec 2025, a change of +3.57 percentage points. The year's high was 33.02% on 29 Aug 2025 and its low 21.11% on 14 Feb 2025, averaging 28.20% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.19 days on 31 Dec 2025. Full history: Hims & Hers Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Hims & Hers Health, Inc. in 2025

2025 in figures

Start of year
25.90% (15 Jan 2025)
End of year
29.47% (31 Dec 2025)
Change
+3.57 pp
High
33.02% (29 Aug 2025)
Low
21.11% (14 Feb 2025)
Average
28.20%
Highest days to cover
6.19 (31 Dec 2025)
SEC filings marked
8

Every report in 2025

Hims & Hers Health, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202525.90%5.86
31 Jan 202526.64%5.24
14 Feb 202521.11%2.29
28 Feb 202523.34%1.0110-K filed, results (8-K)
14 Mar 202524.64%2.30
31 Mar 202526.00%2.71
15 Apr 202527.30%2.46
30 Apr 202528.05%1.80
15 May 202527.85%1.0010-Q filed, results (8-K)
30 May 202527.20%1.80
13 Jun 202527.56%1.39
30 Jun 202530.53%1.05
15 Jul 202529.17%2.40
31 Jul 202528.86%1.84
15 Aug 202531.07%1.9810-Q filed, results (8-K)
29 Aug 202533.02%3.32
15 Sep 202529.44%2.23
30 Sep 202531.42%2.52
15 Oct 202529.59%2.23
31 Oct 202530.82%2.63
14 Nov 202529.67%1.9710-Q filed, results (8-K)
28 Nov 202529.58%3.31
15 Dec 202528.47%4.63
31 Dec 202529.47%6.19

See also: Hims & Hers Health, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.